J
practical approach 5th edition by Virginia P. Arcangelo and
Peterson Chapters 1-56
, TABLE OF CONTENT
Chapter 1: Issues for the Practitioner in Drug Therapy
Chapter 2: Pharmacokinetic Basis of Therapeutics and Pharmacodynamic Principles
Chapter 3: Impac of Drug Interactions and Adverse Events on Therapeutics
J
Chapter 4: Principles of Pharmacotherapy in Pediatrics, Pregnancy and Lactation
Chapter 5: Pharmacotherapy Principles in Older Adults
Chapter 6: Principles of Antimicrobial Therapy
Chapter 7: Pharmacogenomics
Chapter 8: The Economics of Pharmacotherapeutics
Chapter 9: Principles of Pharmacology in Pain Management
Chapter 10: Pain Managemen in Opioid Use Disorder (OUD) Patients
J
Chapter 11: Cannabis and Pain Management
Chapter 12: Dermatitis
Chapter 13: Bacterial, Fungal, and Viral Infections of the Skin
Chapter 14: Psoriasis
Chapter 15: Acne Vulgaris and Rosacea
Chapter 16: Ophthalmic Disorders
Chapter 17: Otitis Media and Otitis Externa
Chapter 18: Hypertension
Chapter 19: Hyperlipidemia
Chapter 20: Chronic Stable Angina and Myocardial Infarction
Chapter 21: Hear Failure
J
Chapter 22: Arrhythmias
Chapter 23: Respiratory Infections
Chapter 24: Asthma and Chronic Obstructive Pulmonary Disease
Chapter 25: Gastric, Functional and Inflammatory Bowel Disorders
Chapter 26: Gastroesophageal Reflux Disease and Peptic Ulcer Disease
Chapter 27: Liver Diseases
, Chapter 28: Urinary Trac Infection
J
Chapter 29: Prostatic Disorders and Erectile Dysfunction
Chapter 30: Overactive Bladder
Chapter 31: Sexually Transmitted Infections
Chapter 32: Osteoarthritis and Gout
Chapter 33: Osteoporosis
Chapter 34: Rheumatoid Arthritis
Chapter 35: Headaches
Chapter 36: Seizure Disorders
Chapter 37: Alzheimer’s Disease
Chapter 38: Parkinson Disease
Chapter 39: Major Depressive Disorder and Bipolar Disorders
Chapter 40: Anxiety Disorders
Chapter 41: Sleep Disorders
Chapter 42: Attention Defici Hyperactivity Disorder
J
Chapter 43: Substance Use Disorders
Chapter 44: Diabetes Mellitus
Chapter 45: Thyroid and Parathyroid Disorders
Chapter 46: Allergies and Allergic Reactions
Chapter 47: Human Immunodeficiency Virus
Chapter 48: Organ Transplantation
Chapter 49: Pharmacotherapy for Selec Thromboembolic Disorders
J
Chapter 50: Anemias
Chapter 51: Immunizations
Chapter 52: Smoking Cessation
Chapter 53: Weigh Loss
J
Chapter 54: Contraception
Chapter 55: Menopause
Chapter 56: Vaginitis
, Chapter 1 Issues for the Practitioner in Drug Therapy
MULTIPLE CHOICE
1. Nurse practitioner prescriptive authority is regulated by:
J J J J J J
A. The National Council of State Boards of Nursing
J J J J J J J
B. The U.S. Drug Enforcement Administration
J J J J
C. The State Board of Nursing for each state
J J J J J J J
D. The State Board of Pharmacy
J J J J
Answer: C J PTS: 1 J J
2. Physician Assistant (PA) prescriptive authority is regulated by:
J J J J J J J
A. The National Council of State Boards of Nursing
J J J J J J J
B. The U.S. Drug Enforcement Administration
J J J J
C. The State Board of Nursing
J J J J
D. The State Board of Medical Examiners
J J J J J
Answer: D J PTS: 1 J J
3. Clinical judgment in prescribing includes:
J J J J
A. Factoring in the cost to the patient of the medication prescribed
J J J J J J J J J J
B. Always prescribing the newest medication available for the disease process
J J J J J J J J J
C. Handing out drug samples to poor patients
J J J J J J
D. Prescribing all generic medications to cut costs J J J J J J
Answer: A J PTS: 1 J J
4. Criteria for choosing an effective drug for a disorder include:
J J J J J J J J J
A. Asking the patient what drug they think would work best for them
J J J J J J J J J J J
B. Consulting nationally recognized guidelines for disease management
J J J J J J
C. Prescribing medications that are available as samples before writing a prescription
J J J J J J J J J J
D. Following U.S. Drug Enforcement Administration (DEA) guidelines for
J J J J J J J J
prescribing
Answer: B J PTS: 1 J J
5. Nurse practitioner practice may thrive under health-care reform due to:
J J J J J J J J J
A. The demonstrated ability of nurse practitioners to control costs and improve patient
J J J J J J J J J J J J
outcomes
B. The fact that nurse practitioners will be able to practice independently
J J J J J J J J J J
C. The fact that nurse practitioners will have full reimbursement under health-care
J J J J J J J J J J J
reform
D. The ability to shift accountability for Medicaid to the state level
J J J J J J J J J J
Answer: A J PTS: 1 J J